Shares of Nabriva Therapeutics plc (NASDAQ:NBRV – Get Free Report) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Nabriva Therapeutics shares last traded at $0.00, with a volume of 0 shares trading hands.
Analyst Ratings Changes
Separately, StockNews.com started coverage on Nabriva Therapeutics in a report on Friday. They set a “hold” rating for the company.
View Our Latest Report on NBRV
Nabriva Therapeutics Trading Down 100.0 %
About Nabriva Therapeutics
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for oral and IV administration.
Read More
- Five stocks we like better than Nabriva Therapeutics
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- How to Calculate Options Profits
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Investing in Travel Stocks Benefits
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Nabriva Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nabriva Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
